The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry (Q71828075)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

Chen S

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Chou WH

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Blouin RA

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Mao Z

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Humphries LL

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Meek QC

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Neill JR

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Martin WL

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Hays LR

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Wedlund PJ

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 November 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941025%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

522-534

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941025%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941025%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1016/s0009-9236(96)90148-4

21 October 2019

exact match

0 references

cites work

Clinical significance of the sparteine/debrisoquine oxidation polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

Pharmacogenetic phenotyping and genotyping. Present status and future potential.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

"It's the genes, stupid". Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

7 January 2021

Isolation of genomic DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

Purification of human genomic DNA from whole blood using sodium perchlorate in place of phenol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

DNA haplotype dependency of debrisoquine 4-hydroxylase (CYP2D6) expression among extensive metabolisers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

Interpretation of a simple PCR analysis of the CYP2D6(A) and CYP2D6(B) null alleles associated with the debrisoquine/sparteine genetic polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

Polymorphisms in oxidative drug metabolism: relationship to food preference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

A rapid method for the purification of DNA from blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

Cloning and sequencing of a new non-functional CYP2D6 allele: deletion of T1795 in exon 3 generates a premature stop codon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

A missense mutation in exon 6 of the CYP2D6 gene leading to a histidine 324 to proline exchange is associated with the poor metabolizer phenotype of sparteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

Polymorphic debrisoquin hydroxylation in 757 Swedish subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

Evidence for a new variant CYP2D6 allele CYP2D6J in a Japanese population associated with lower in vivo rates of sparteine metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

Debrisoquin and mephenytoin hydroxylation phenotypes and CYP2D6 genotype in patients treated with neuroleptic and antidepressant agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

In vitro approaches can predict human drug metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

Use of in vitro human metabolism studies in drug development. An industrial perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

Metabolism of theophylline by cDNA-expressed human cytochromes P-450.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: polymorphism in RFLP and DNA sequence of CYP2D6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4

Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990148-4